| Shikonin derivative DMAKO-05 inhibits akt signal activation and melanoma proliferation | |
| Yang Y.-Y.3; He H.-Q.3; Cui J.-H.3; Nie Y.-J.3; Wu Y.-X.3; Wang R.1; Wang G.2; Zheng J.-N.2; Ye R.D.3; Wu Q.1; Li S.-S.3; Qian F.3 | |
| 2016-06-01 | |
| Source Publication | Chemical Biology and Drug Design
 |
| ISSN | 17470285 17470277 |
| Volume | 87Issue:6Pages:895-904 |
| Abstract | DMAKO-05((S)-1-((5E,8E)-5,8-bis(hydroxyimino)-1,4-dimethoxy-5,8-dihydronaphthalen-2-yl)-4-methylpent-3-enyl 3-methylbutanoate) is a novel oxime derivative of shikonin, the major component extracted from Chinese herb Lithospermun erythrorhizon. Here, we report that DMAKO-05 had an antitumor activity against mouse melanoma cell line B16F0. Our studies indicated that DMAKO-05 not only inhibited B16F0 proliferation and migration but also led to cell cycle arrest at G1 phase and cell apoptosis, in which DMAKO-05 triggered mitochondrial-mediated apoptosis signal including caspase-9/3 and PARP. In response to DMAKO-05 treatment, the Akt-mediated survival signals were remarkably attenuated in B16F0 cells. Collectively, DMAKO-05 has a strong cytotoxicity in B16F0 cells via inhibiting Akt activation, inducing G1 arrest, and promoting B16F0 cell apoptosis. DMAKO-05 might serve as a potential candidate lead compound for melanoma. The novel oxime derivative of shikonin DMAKO-05 was found toxic to melanoma cell B16F0. DMAKO-05 remarkably inhibited the phosphorylation of Akt, induced G1 cell cycle arrest, and promoted B16F0 melanoma cell apoptosis. DMAKO-05 might serve as a potential inhibitor for melanoma. |
| Keyword | apoptosis cell cycle arrest cytotoxicity DMAKO-05 melanoma cell B16F0 shikonin |
| DOI | 10.1111/cbdd.12722 |
| URL | View the original |
| Language | 英語 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Journal article |
| Collection | University of Macau |
| Affiliation | 1.Bengbu Medical College 2.XuZhou Medical University 3.Shanghai Jiao Tong University |
| Recommended Citation GB/T 7714 | Yang Y.-Y.,He H.-Q.,Cui J.-H.,et al. Shikonin derivative DMAKO-05 inhibits akt signal activation and melanoma proliferation[J]. Chemical Biology and Drug Design,2016,87(6):895-904. |
| APA | Yang Y.-Y..,He H.-Q..,Cui J.-H..,Nie Y.-J..,Wu Y.-X..,...&Qian F..(2016).Shikonin derivative DMAKO-05 inhibits akt signal activation and melanoma proliferation.Chemical Biology and Drug Design,87(6),895-904. |
| MLA | Yang Y.-Y.,et al."Shikonin derivative DMAKO-05 inhibits akt signal activation and melanoma proliferation".Chemical Biology and Drug Design 87.6(2016):895-904. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment